Publications by authors named "Joel Santos-Bolivar"
Objective: To measure macrophage migration inhibitory factor (MIF) concentrations in obese and non-obese women diagnosed with polycystic ovary syndrome (PCOS).
Methods: Women diagnosed with PCOS and age-matched healthy controls with regular menses and normal ovaries on ultrasound examination were selected and divided into 4 groups (group A, PCOS and obese; group B, PCOS and non-obese; group C, obese controls; and group D, non-obese controls) based on body mass index (obese >30 kg/m2 and non-obese <25 kg/m2). Luteinizing hormone, follicle-stimulating hormone, androstenedione, testosterone, sex hormone-binding globulin, serum glucose, insulin and MIF levels were measured.
Background And Objective: To compare the values of the atherogenic index of plasma between preeclamptic patients and healthy pregnant women.
Patients And Method: Seventy patients were selected. Twenty-three severe preeclamptic patients (group A), 12 mild preeclamptic patients (group B) and 35 healthy pregnant women with similar age and body mass index (group C).
Objective: To assess plasma renin and aldosterone levels in obese and non-obese women with polycystic ovary syndrome (PCOS).
Methods: Obese women (body mass index [BMI]>30 kg/m2; group A, n=34) and non-obese women (BMI<25 kg/m2; group B, n=13) with PCOS were selected. The control group (groupC, n =47) consisted of age-matched women with regular menses and normal ultrasonographic ovaries.
Objective: To assess lipid profile changes in post-menopausal women treated with testosterone gel.
Methods: Thirty-six oophorectomized women on estradiol treatment who received transdermal testosterone gel (5mg daily) were enrolled into our study. Cholesterol, triglycerides, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), very low density-lipoprotein cholesterol (VLDL-C), and lipoprotein (a) were tested before and after 6 months of treatment.
Objective: To compare endothelial microparticles values in eclamptic, preeclamptic and normotensive pregnant women.
Materials And Methods: Patients were selected among those who assisted to Obstetrics Emergency at Hospital Central "Dr. Urquinaona", Maracaibo, Venezuela.
Objective: To compare lipid and lipoprotein concentrations between obese and non-obese women with a diagnosis of polycystic ovary syndrome (PCOS) treated with metformin for 6 months.
Methods: Sixty-five women with a diagnosis of PCOS were included. The presence of obesity, serum concentrations of cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) were recorded before and after 6 months of metformin treatment.